Market News
Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth prompted Elara Securities to raise its earnings estimates, the brokerage downgraded the stock to ‘Accumulate’ from ‘Buy’ after its 40% three-month rally, citing limit
Nifty's price-to-book ratio has dipped below three for the first time in years, highlighting a significant shift. Despite this, earnings remain at high valuations, suggesting minimal potential for multiple expansions. Future advancement in the market will depend more on profit enhancements instead o
Info Edge shares jumped over 4% after the company reported a strong Q1 FY27 performance, with consolidated net profit rising 43% year-on-year to Rs 490 crore. Recruitment billings grew 17.5%, while operating profit rose 25%. Nomura, Nuvama and Motilal Oswal retained their respective ratings, with No
Japan faces record izakaya bankruptcies, signaling change of drink culture
Hong Kong’s main technology stock benchmark is set for a revamp to include more companies representing the fast-growing artificial intelligence and robotics sectors, a long‑awaited move for investors eager to better capture China’s technological advances.
The yuan’s recent calm run may be nearing an end as September approaches, with typically strong fall exports and other seasonal factors expected to lift the Chinese currency, analysts say.
How Beijing turned its food insecurity into geopolitical leverage.
How fragile states can fortify themselves.
automated-news
Further scrutiny and accountability would strengthen independence
automated-news
What some see as an alarming population explosion could be just what the continent needs